Zhu X - Search Results

1

Circular RNA circRPPH1 promotes triple-negative breast cancer progression via the miR-556-5p/YAP1 axis.

Zhou Y, Liu X, Lan J, Wan Y, Zhu X. Zhou Y, et al. Among authors: zhu x. Am J Transl Res. 2020 Oct 15;12(10):6220-6234. eCollection 2020. Am J Transl Res. 2020. PMID: 33194025 Free PMC article.

2

Long Noncoding RNA LINC02163 Accelerates Malignant Tumor Behaviors in Breast Cancer by Regulating the MicroRNA-511-3p/HMGA2 Axis.

Qin C, Jin L, Li J, Zha W, Ding H, Liu X, Zhu X. Qin C, et al. Among authors: zhu x. Oncol Res. 2020 Dec 10;28(5):483-495. doi: 10.3727/096504020X15928179818438. Epub 2020 Jun 22. Oncol Res. 2020. PMID: 32571448 Free PMC article.

3

TNFRSF9 Suppressed the Progression of Breast Cancer via the p38MAPK/PAX6 Signaling Pathway.

Liu X, Zhou Y, Qin C, Zhu X. Liu X, et al. Among authors: zhu x. J Oncol. 2022 Jun 28;2022:8549781. doi: 10.1155/2022/8549781. eCollection 2022. J Oncol. 2022. PMID: 35799609 Free PMC article.

4

TCRP1 induces tamoxifen resistance by promoting the activation of SGK1 in MCF‑7 cells.

Zhao S, Li X, Yin L, Hou L, Lan J, Zhu X. Zhao S, et al. Among authors: zhu x. Oncol Rep. 2020 Jun;43(6):2017-2027. doi: 10.3892/or.2020.7577. Epub 2020 Apr 3. Oncol Rep. 2020. PMID: 32323833 Free PMC article.

5

LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer.

Song Z, Wang X, Chen F, Chen Q, Liu W, Yang X, Zhu X, Liu X, Wang P. Song Z, et al. Among authors: zhu x. Front Oncol. 2022 Sep 21;12:1004212. doi: 10.3389/fonc.2022.1004212. eCollection 2022. Front Oncol. 2022. PMID: 36212476 Free PMC article.

6

Clinicopathological significance of Sox10 expression in triple-negative breast carcinoma.

Jin L, Qin C, Qi X, Hong T, Yang X, Zhu X. Jin L, et al. Among authors: zhu x. Transl Cancer Res. 2020 Sep;9(9):5603-5613. doi: 10.21037/tcr-20-2634. Transl Cancer Res. 2020. PMID: 35117924 Free PMC article.

7

LINC00680 modulates docetaxel resistance in breast cancer via the miR-320b/CDKL5 axis.

Li J, Ke J, Qin CL, Zhu X. Li J, et al. Among authors: zhu x. Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221105608. doi: 10.1177/03946320221105608. Int J Immunopathol Pharmacol. 2022. PMID: 35667653 Free PMC article.

8

Downregulation of RIP140 in triple-negative breast cancer inhibits the growth and proliferation of cancer cells.

Yu XH, Xue X, Zhu X, Li X. Yu XH, et al. Among authors: zhu x. Oncol Lett. 2018 Jun;15(6):8784-8788. doi: 10.3892/ol.2018.8434. Epub 2018 Apr 5. Oncol Lett. 2018. PMID: 29844812 Free PMC article.

9

Overexpression of ROD1 inhibits invasion of breast cancer cells by suppressing the translocation of β-catenin into the nucleus.

Zhou Y, Zou H, Wu E, Huang L, Yin R, Mei Y, Zhu X. Zhou Y, et al. Among authors: zhu x. Oncol Lett. 2018 Aug;16(2):2645-2653. doi: 10.3892/ol.2018.8917. Epub 2018 Jun 6. Oncol Lett. 2018. PMID: 30013660 Free PMC article.

10

Recurrent Superenhancer of the Oncogene POU5F1B in Colorectal Cancers.

Tao HC, Wang C, Ma N, Zhu X, Zhou XJ. Tao HC, et al. Among authors: zhu x. Biomed Res Int. 2021 Dec 11;2021:5405060. doi: 10.1155/2021/5405060. eCollection 2021. Biomed Res Int. 2021. PMID: 34934770 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,014 results

Search Page

Filters